AdvancedCPR Solutions®, develops novel resuscitation technologies to improve the likelihood of survival after sudden cardiac arrest (SCA). Co-founded by a seasoned entrepreneur who has introduced numerous disruptive medical devices globally and a physician researcher widely recognized as one of the world’s experts on CPR, the company has assembled an experienced team of scientists, clinicians, and engineers dedicated to transforming the cardiac arrest landscape. The company is now commercializing its first product, the EleGARD™ Patient Positioning System, which could significantly improve survival from SCA.
AdvancedCPR Solutions developed the EleGARD System based upon preclinical studies showing that device-assisted sequential elevation of the head, heart, and thorax during CPR results in near normal cerebral perfusion pressures and a six-fold higher neurologically-intact survival rate compared to conventional manual CPR in the supine position.1,2 Multiple US device and methods issued patents protect the EleGARD and device-assisted sequential elevation of the head and thorax (trademarked by the company as the ElevatedCPR® method), the first major CPR breakthrough in decades. The company’s EleGARD System is the only device that precisely, rapidly, and consistently positions patients for delivery of the ElevatedCPR method in the pre-hospital and hospital settings. It is anticipated that the ElevatedCPR method will increase the likelihood for neurologically-intact survival and also increase the number of patients who could benefit from advanced cardiac management technologies, from coronary stents to implantable defibrillators.
ACS has partnered with market leading firms to carry out product engineering, manufacturing, service, QA/RA, logistics, and customer service. ACS will employ the proven professionals needed to provide direct clinical and sales support, clinical evidence development, and product innovation.
PHILIP W. FARIS
Founder, CEO & Director
KEITH G. LURIE, M.D.
Founder, CMO & Director
GLENN ROBINSON, CPA
Chief Financial Officer
ANJA METZGER, PhD
VP Clinical and Preclinical Affairs
KIM MARIE MACYGIN, MSN, RN, CEN
Vice President of Clinical Education
LISA M. OWENS
Vice President Marketing Strategy & Communications
Scientific Advisory Board
For Investment Information
Complete this contact form and a company representative will contact you directly.
December 4, 2020